Company Filing History:
Years Active: 2002-2007
Title: The Innovative Contributions of Frederick Libert
Introduction
Frederick Libert is a notable inventor based in Braine-l'Alleud, Belgium. He has made significant contributions to the field of biomedical research, particularly in the development of methods to combat HIV. With a total of 5 patents to his name, Libert's work has the potential to impact public health positively.
Latest Patents
Among his latest patents, Libert has developed screening methods for identifying compounds that decrease HIV entry into a cell. This innovation involves a peptide with an amino acid sequence that has more than 80% homology with the sequence listed as SEQ ID NO:4. Additionally, a nucleic acid molecule has been identified that shows more than 80% homology with one of the nucleic acid sequences listed as SEQ ID NO:1, SEQ ID NO:2, and SEQ ID NO:3. The use of ligands, anti-ligands, and cell vectors related to the peptide and/or nucleic acid molecule is also included in this patent. Another significant patent focuses on CCR5 chemokine receptor-specific antibodies, which similarly utilize a peptide and nucleic acid molecules with high homology to the specified sequences.
Career Highlights
Frederick Libert is currently associated with Euroscreen S.A., a company dedicated to advancing drug discovery and development. His work at Euroscreen has allowed him to explore innovative solutions to pressing health issues, particularly in the realm of infectious diseases.
Collaborations
Throughout his career, Libert has collaborated with esteemed colleagues such as Michel Samson and Marc Parmentier. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic approaches.
Conclusion
Frederick Libert's contributions to the field of biomedical research, particularly in the fight against HIV, highlight his innovative spirit and dedication to improving health outcomes. His patents and collaborations reflect a commitment to advancing scientific knowledge and developing effective treatments.